Exposure to cisplatin in the operating room during hyperthermic intrathoracic chemotherapy

URN to cite this document:: urn:nbn:de:bvb:355-epub-462890
DOI to cite this document:: 10.5283/epub.46289

Markowiak, Till

; Ried, Michael

; Larisch, Christopher ; Nowak, Dennis ; Hofmann, Hans-Stefan ; Rakete, Stefan

Preview

License: Creative Commons Attribution 4.0
PDF - Published Version
(1MB)

Date of publication of this fulltext: 07 Jul 2021 06:38

Alternative links to fulltext:DOI Publisher

This publication is part of the DEAL contract with Springer.

Details

Preview

Indexed in

Export bibliographical data

Abstract

Purpose Hyperthermic intrathoracic chemotherapy (HITOC) is an additive, intraoperative treatment for selected malignant pleural tumors. To improve local tumor control, the thoracic cavity is perfused with a cisplatin-containing solution after surgical cytoreduction. Since cisplatin is probably carcinogenic to humans, potential contamination of surfaces and pathways of exposure should be ...